Theranautilus raises $1.2 Mn in seed round led by pi Ventures

Theranautilus, a deep-tech firm developing nanorobotic solutions for healthcare, has raised $1.2 million in its seed round led by pi Ventures. The round also saw participation from Golden Sparrow Ventures and angel investors including Abhishek Goyal, founder and CEO of Tracxn, and Lalit Keshre, CEO of Groww. 

The proceeds will be used to commercialize nanorobotics-based medical devices, initially targeting dental care applications, the company said in a press release. The funds will also be utilized to develop Theranautilus's go-to-market strategy and to advance its efforts in extending the innovative technology beyond dental applications.

Founded in 2020 by Ambarish Ghosh, Debayan Dasgupta, and Peddi Shanmukh Srinivas, Theranautilus develops innovative nanorobotic solutions that address critical dental health challenges. This platform is set to transform issues like dental hypersensitivity, which affects over 2 billion people worldwide and represents a $6 billion market. 

It offers a long-term solution by using precision-manufactured nanorobots to targeted locations within dental tissues to deliver biocompatible materials. These materials can be externally triggered to form bio-mimetic structures that repair damaged tissue, providing lasting relief. 

Theranautilus, backed by international patents and technology, aims to develop and commercialize precision theranostics-based interventions to manage cancer therapy and other diseases.